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■Introduction
Pigmented villonodular synovitis (PVS) is a rare
synovitis of chiefly the knee joints of adults in the
synovial tissue. It invades the subchondral bone of the
joint or the soft tissue１）. The histopathogenesis of PVS
remains obscure. Cytogenetic studies have contributed
to a better understanding of the histopathogenesis of
unknown pathology and have revealed specific
anomalies in some, such as tumors or their related
conditions, that have proved useful diagnostically２）. In
this study, the cytogenetic findings of PVS of the ankle
are described.
■Case report
A51-year-old Japanese woman complained of
progressive pain and swelling of the left ankle. From
1988, she had a gradually growing mass in the left
ankle. In August 1993, she underwent first surgical
resection of the mass. After that, she underwent
surgical treatments four times, because the tumors
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Abstract
Cytogenetic studies of pigmented villonodular synovitis (PVS), a rare tumor−like synovitis of
adults, are few. A characteristic anomaly has not yet been identified for this pathology. In this
study, cytogenetic analysis of a recurrent PVS of a 51−year−old female revealed the following
clonal abnormalities: trisomies 5 and 7. These findings support that some cases of PVS represent
clonal neoplastic proliferations. The literature data about cytogenetic aberrations in PVS and its
related pathology, are reviewed.
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Fig. 1 T1-weighted MRI demonstrates a heterogenous ill-defined low signal intensity mass of the ankle joint with soft tissue
extension. The lesion extended to the talus and subtalar joint (A: coronal section, B: axial section, TR/TE: 570/12).
An angiogram shows hypervascular masses around the ankle (C).
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recurred, repeatedly. Pathological diagnosis was PVS
every time. However, the mass failed to disappear
completely. She noticed slowly progressive swelling of
her ankle with intermittent flares of pain again. In
2001, seven months after the last operation, she had
recurrence of the left ankle PVS again; the pain
increased markedly and her walking was difficult. On
physical examination, one localized soft tissue mass (6x
3cm) was on the anterior aspect of the left foot and the
other mass was more diffuse laterally (5x2cm). She felt
mild tenderness around these lesions.
Plain radiographs showed multiple subchondral
erosions indicating arthritis in the left ankle joint (Fig.
1). Magnetic resonance imaging (MRI) confirmed intra-
and peri-articular soft tissue masses in the ankle and
subtalar joint. In both T1-and T2-weighted images,
these lesions showed low signal intensity (Fig. 2). An
angiogram showed three hypervascular masses of the
ankle and foot (Fig. 3). Two ankle masses were
palpable, but another foot mass was clinically free of
symptom.
We performed synovectomy of the ankle and
subtalar joints, as much as we could. The findings of
synovium looked like soft tissue masses, and changed
to yellowish color. We removed these lesions piece by
piece. A portion of the resection was submitted for
pathological study and cytogenetic analysis. Histologic
examination showed enlarged villi with synovial cell
proliferation, chronic inflammatory cells, numerous
hemosiderin-laden histiocytes, and scattered multinu-
cleated giant cells. Xanthomatous areas with foamy
lipid-laden histiocytes were observed with hyalinized
collagen (Fig. 2). The tissue was minced with collage-
nase. After enzymatic disaggregation, the cells were
resuspended in RPMI 1640 (Gibco, Long Island, NY)
supplemented with 20% fetal bovine serum and
antibiotics, and were cultured for 7 days. Metaphase
chromosomes were banded with Giemsa-trypsin. The
karyotypes were described according to the Inter-
national System for human Cytogenetic Nomenclature
Fig. 2 Representative histologic specimen showing spaces
and villi of PVS located by plump layers of synovial
cells and hemosiderin laden macrophages (HE. X
100).
Fig. 3 A representative karyogram with the following chromosomal component: 46, XY, +5, +7.
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(ISCN) 19953. Twenty metaphase cells were examined.
Nine cells were karyotypically abnormal and were
characterized as: 48, XX, +5, +7 [7cells], 47, XX, inv(3)(p
21;q25), +7[1cell], 46,XX, add(5)(q13), +7,- 10, t(11;21)(q13;
p13), -18, +mar [1 cell]. Other eleven cells showed a
normal female chromosomal complement. Figure 3
shows a representative karyogram showing both
trisomies 5 and 7, which are observed in 7 cells of 9
abnormal metaphases (78%).
After surgery the patient felt a diminishing of the
swelling of the ankle. The follow-up periods were 3
years after surgery. The patient was informed that the
data from the case would be submitted for publication
and their consent.
■Discussion
PVS is a rare condition of unknown etiology. It
occurs most commonly in knee joints, but rarely in the
ankle４～９）. It is characterized by nodular or diffuse
proliferation of synovial and mesenchymal supporting
elements within tendon sheaths or synovial joints. The
stroma contains chronic inflammatory cells, hemo-
siderin-laden histiocytes, and multinuclear giant cells.
Varying degrees of collagen are within lesions, and
xanthomatous lesions are often present. Occasionally,
synovitis extends into underlying bone. Three related
forms of synovitis have been described: an isolated
lesion with tendon sheaths (giant cell tumor of the
tendon sheath), a solitary intraarticular nodule
(localized nodular synovitis), and a diffuse, often villous,
pigmented process with synovial tissue (PVS)４）.
Genetic factors might be important in the develop-
ment of the synovitis. Cytogenetic analysis of our case
showed the following clonal abnormalities: 48, XX, +5,
+7. We reviewed the cytogenetic data of PVS and its
related pathology (Table 1) ４，７，１０～１５）. Similar cytoge-
netic aberrations (trisomy 5 or 7) were reported in 5
cases so far.
Trisomy 7 has been also described as an isolated
aberration in the other neoplasms, such as angio-
myolipoma１６）or fibromatosis１７）. The oncogene c-erb B
coding for the epidermal growth factor receptor
(EGFR) has been located on chromosome 7１８）. Another
potentially relevant gene that has been mapped to
chromosome 7 is the platelet-derived growth factor
(PDGF) A chain１９）; this growth factor is a mitogenic
stimulant for a wide variety of cell types. However, the
specific cell type responsible for the neoplastic
secretion has not been identified. Trisomy 5 with
constitutional aberrations has reported in a chondro-
Table 1 Cytogenetic abnormal clonalities in PVS and its related pathology
Case Cytogenetic abnormal clonalities Histological diagnosis References
47/M Trisomy 5, Trisomy 7, Trisomies 5 and 7 PVS Ray RA (1991)7)
48/F Trisomy 7, Trisomies 5 and 7 PVS Fletcher JA (1992)12)
18/M
Trisomy 5, Trisomy7, Trisomies 5 and 7
45, XX, t(1;2) (pter->p22::q24->pter),
t(1:14) (qter->p13::q13->pter)
Diffuse type-giant
cell tumors
Gonzalez-Campora R
(1995)13)
35/F
X chromosome inactivation
47, X, -X, del(1)(p32), add(3) (q21),
+der(5) t(5;8)(p15;q22), +i(7)q10,
der(8) t(p13;q11), der(13) t(5;13) (q11;p11),
add(16) (p11) der(21), t(8;21) (q13q22)/
46, idem, -10, add(19) (q13)
Nodular synovitis Choong PFM (1995)4)
53/F
Short chromosome 1
47, XX, +7
PVS Ohjimi Y (1996)15)
1) 24/F
2) 65/F
Trisomy 5, Trisomy 7, Trisomies 5 and 7
Trisomy 7, Trisomies 5 and 7
Malignant PVS Layfield LJ (2000)14)
1) 46/F
2) 26/F
3) 57/F
48, XX, t(1;12)(p13;q24), +5, +7
46, XX
46, XX, add(1) (p11), add(1) (q32), der(22) t(1;22)
(q21;q13) ins(1;?) (q32;?)
PVS Dahlen A (2001)11)
15 cases gain of 22q, 16p and 16q PVS Berger I (2005)10)
51/F 48, XY, +5, +7 PVS Present case
KANAMORI et al. : Cytogenetic findings of PVS 33
blastoma case２０）, but its tumorigenecity is remaining
uncertain. Our cytogenetic findings strongly suggest
neoplastic secretion by growth factors on chromo-
somes 5 and 7. These aberrations might contribute to
the clonal neoplastic proliferations of PVS. Additional
cases, however, must be examined to understand the
relevance of our findings.
In summary, we added the new case of PVS
showing cytogenetic aberrations of trisomies 5 and 7.
■Acknowledgements
We thank Christopher Moreby (Science English
Checking) for the expert secretarial service.
REFERENCES
１）Enzinger F. M., Weiss S. W.: Soft tissue tumors. 3rd ed.
742―749, St. Louis, Mosby, 1995.
２）Sanberg A. A., Bridge J. A.: The cytogenetics of bone
and soft tissue tumors. 403―407, Austin, R. G. Landes
Company, 1994.
３）Mitelman F. (ed).: Guidelines for cancer cytogenetics.
Supplement to an International System for Human
Cytogenetic Nomenclature. Basel, Switzerland, S.
Karger, 1995.
４）Choong P. F. M., Willen H., Nilbert M., et al.: Pigmented
villonodular synovitis. Monoclonality and metastasis -a
case for neoplasic origin? Acta Orthop. Scand. 66: 64―8,
1995
５）Kaneko K., Nakahara D., Tobe M., et al.: Pigmented
villonodular synovitis of the ankle in an adolescent. Int.
Orthop. 24: 234―237, 2000.
６）Rao S., Vigorita V. J.: Pigmented villonodular synovitis
(Giant-cell tumor of the tendon sheath and synovial
membrane). J. Bone Joint Surg. [Am] 66: 76―94, 1984.
７）Ray R. A., Morton C. C., Lipinski K. K., et al.:
Cytogenetic evidence of clonality in a case of pig-
mented villonodular synovitis. Cancer 67:121―125, 1991.
８）Rowlands C. G., Roland B., Hwang W. S., et al.: Diffuse-
variant tenosynovial giant cell tumor: A rare and
aggressive lesion. Hum. Pathol. 25: 423―425, 1994.
９）Ushijima M., Hashimoto H., Tsuneyoshi, M. et al.:
Pigmented villonodular synovitis. A clinicopathologic
study of 52 cases Acta Pathol. Jpn. 36: 317―326, 1986.
１０）Berger I., Rieker R., Ehemann V., et al.: Analysis of
chromosomal imbalances by comparative genomic
hybridization of pigmented villonodular synovitis.
Cancer Letters 220: 231―276, 2005.
１１）Dahlen A., Broberg K., Domanski H. A., et al.: Analysis
of the distribution and frequency of trisomy7in vivo in
synovia from patients with osteoarthritis and
pigmented villonodular synovitis. Cancer Genet .
Cytogenet. 131: 19―24, 2001.
１２）Fletcher J. A., Henkle C., Atkins L., et al: Trisomy 5
and trisomy 7 are nonrandom aberrations in
pigmented villonodular synovitis: Confirmation of
trisomy 7 in uncultured cells. Genes Chrom. Cancer 4:
264―426, 1992.
１３）Gonzalez-Campora R., Herrero E. S., Otal-Salaverri C.,
et al.: Diffuse tenosynovial giant cell tumor of soft
tissues. Acta Cytologica 39: 770―776, 1995.
１４）Layfield L.J., Meloni-Ehrig A., Katharine L., et al.:
Malignant giant cell tumor of synovium (malignant
pigmented villonodular synovitis). Arch Pathol. Lab.
Med. 124: 1636―4161, 2000.
１５）Ohjimi Y., Iwasaki H., Ishiguro M., et al.: Short arm of
chromosome 1 aberration recurrently found in
pigmented villonodular synovitis. Cancer Genet .
Cytogenet. 90: 80―85, 1995.
１６）De jong B., Castedo S. M. M. J., Oosterhuis J. W., et al:
Trisomy 7 in a case of angiomyolipoma. Cancer Genet.
Cytogenet. 34: 219―222, 1998
１７）Somers K. D., Winters B. A., Dawson D. M., et al.:
Chromosome abnormalities in Peyronie’s disease. J.
Urol. 137: 672―5, 1987.
１８）Kondo I., Shimizu N.: Mapping of the human gene for
epidermal growth factor receptor (EGFR) on the p13-q
22 region of chromosome 7. Cytogenet. Cell Genet. 35: 9
―14, 1983.
１９）Bonthron D. T., Morton C. C., Orkin S. H., et al: Platelet-
derived growth factor A chain: Gene structure,
chromosomal location, and basis for alternative mRNA
splicing. Proc. Natl. Acad. Sci. USA 85: 1492―1496, 1988.
２０）Swarts S. J., Neff J. R., Johansson S. L., et al.: Signifi-
cance of abnormalities of chromosomes 5 and 8 in
chondroblastoma. Clin. Orthop. 349: 189―193, 1988.
Toyama Medical Journal Vol. 19 No. 1 200834
